Cart
sales@molnova.com
LY2033298
CAS No. 886047-13-8
LY2033298( —— )
Catalog No. M34325 CAS No. 886047-13-8
LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | In Stock |
|
| 5MG | 204 | In Stock |
|
| 10MG | 351 | In Stock |
|
| 25MG | 769 | In Stock |
|
| 50MG | 1040 | In Stock |
|
| 100MG | 1377 | In Stock |
|
| 500MG | 2673 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2033298
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.
-
DescriptionLY 2033298 is a selective positive allosteric modulator of the muscarinic M4 receptor. LY 2033298 can be used in the study of psychiatric disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number886047-13-8
-
Formula Weight311.79
-
Molecular FormulaC13H14ClN3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chan WY, et al. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10978-83.?
molnova catalog
related products
-
SIB 1553A
SIB 1553A is an orally available and selective agonist of nicotinic acetylcholine receptors (nAChRs), which are subtype-selective ligands for nicotinic acetylcholine receptors.
-
(S)-UFR2709 hydrochl...
(S)-UFR2709 (hydrochloride) is a competitive nAChR antagonist with higher affinity for α4β2 nAChRs than for α7 nAChRs.
-
NS3861
NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and bind with high affinity to heteromeric α3β4 and α4β2 nAChRs.
